Clinical Trial Update: Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial of celecoxib as adjuvant biologic therapy in patients with head and neck cancer and lung cancer. The study was terminated, and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Cancer, Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-04-20